PRESS-RELEASE ·Filed May 8, 2026
Press release · Earnings
Final — all horizons settled through T+60d
BFRI ▲ +11.71% at T+60d
NEUTRAL call +11.71% · α vs SPY +7.32% · entry $1.11 → $1.24
T+1d
0.00%
call 0.00% · α +0.14%
$1.11
settled 6mo ago
T+5d
-28.38%
call -28.38% · α -28.29%
$0.7950
settled 5mo ago
T+20d
-20.72%
call -20.72% · α -20.42%
$0.8800
settled 5mo ago
T+60d
+11.71%
call +11.71% · α +7.32%
$1.24
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Biofrontera Inc. announced it will report its Q1 2026 results on May 14, 2026.
Key Facts
- Biofrontera Inc. announced it will report its Q1 2026 results on May 14, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291315 |
6 reports for BFRI
67% Hit rate @ T+60 Went positive at some point 3 of 5 best @ T+20▲ +28.50%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | 8-K | $1.36 | awaiting T+60 | — | $0.8098 (−40.46%) |
Aug 13, 2026 10w ago | 8-K | $1.26 | awaiting T+60 | — | $0.8098 (−35.73%) |
May 14, 2026 23w ago | Press Release | $0.9890 $1.21 | ▲ +22.35% | ▲ +18.76% | $0.8098 (−18.12%) |
May 8, 2026 24w ago | Press Release | $1.11 $1.24 | ▲ +11.71% | ▲ +7.32% | $0.8098 (−27.05%) |
Mar 19, 2026 31w ago | Press Release | $0.8560 $1.00 | ▲ +16.82% | ▲ +2.48% | $0.8098 (−5.40%) |
Feb 26, 2026 34w ago | 8-K | $0.9270 $0.7790 | ▼ −15.97% | ▼ −23.72% | $0.8098 (−12.64%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 5h 17m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers